Relationship between use of proton pump inhibitors and IGF system in older subjects. - Wikidata - awgldk - TriplyDB

Relationship between use of proton pump inhibitors and IGF system in older subjects.

Relationship between use of proton pump inhibitors and IGF system in older subjects.

http://www.wikidata.org/entity/Q37361889

about

Inappropriate Use of Proton Pump Inhibitors in Elderly Patients Discharged from Acute Care Hospitals.Polypharmacy as a Risk Factor for Clinically Relevant Sarcopenia: Results From the Berlin Aging Study II.

P2860

Q39702517-CE25D851-F690-474C-845D-A637260456D1 Q47770687-F274D19A-9D52-4878-9636-D36A214AD8E4

P2860

Relationship between use of proton pump inhibitors and IGF system in older subjects.

http://www.wikidata.org/entity/Q37361889

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Relationship between use of proton pump inhibitors and IGF system in older subjects.

@en

Relationship between use of proton pump inhibitors and IGF system in older subjects.

@nl

type

label

Relationship between use of proton pump inhibitors and IGF system in older subjects.

@en

Relationship between use of proton pump inhibitors and IGF system in older subjects.

@nl

prefLabel

Relationship between use of proton pump inhibitors and IGF system in older subjects.

@en

Relationship between use of proton pump inhibitors and IGF system in older subjects.

@nl

P1433

Q37361889-FC296B6C-46E0-483D-A595-CECE0568D7FB

P1476

Q37361889-58B2DBDC-3CCF-49BB-9AAF-E5039A0D7FD0

P2093

Q37361889-133C9550-FBF0-42B9-81B6-D965F4BC9B9F

Q37361889-36AC45E1-9658-4589-90CC-D0D1CDA6B560

Q37361889-38CFF482-F0BA-4F35-BDEB-51FD144B2FED

Q37361889-3B436296-45D5-4C2B-A36D-C59E852C76FB

Q37361889-5009A376-50ED-4496-ADBC-D0E77586EEB2

Q37361889-6857A1B8-6BB2-4BCC-9FDE-58211284D72A

Q37361889-6D34C574-6CCA-4CEF-A746-F6E762CDE4D9

Q37361889-76C4DFC3-51EC-4FB8-BE63-18EB0582EF52

Q37361889-AECA6B06-65F0-4E8C-8E4A-58F71359227D

Q37361889-BD56A23E-35C8-4045-A694-3AA04E5CB6A1

P2860

Q37361889-18537EED-48AF-460E-97A3-395124AF90F5

Q37361889-1CCB9D23-F42E-469A-B808-941A2A9F0A72

Q37361889-2898368E-17AC-4371-BBA0-7B0500D76F9A

Q37361889-31A02DBC-B0B2-459F-81CF-F97F4EC1420B

Q37361889-47617B4B-7EB5-4DAE-A5CD-C58EE3885794

Q37361889-9FB0EAB2-23FD-4F0F-9C3F-9C0849033133

Q37361889-A52C8CE5-101E-4BFA-8FF6-E989C2C311CE

Q37361889-AB244D15-5B0E-419A-83E7-8C07B0644B33

Q37361889-AC9F2F7E-05DE-4324-BBDE-F3C6311BEEEF

Q37361889-BB046C7B-84B7-4786-8862-3209394FAEB7

P2888

Q37361889-78F7172F-D8B4-475D-842D-C1167A6CBECF

P304

Q37361889-77843D63-47DF-4051-BFE1-D197F5F30411

P31

Q37361889-3988DB13-9C70-4D68-A954-1DE1CBAC1352

P356

Q37361889-C3B73F21-3432-452B-B9F1-1232721349D7

P433

Q37361889-D7F5792E-F3F8-49C2-BBBC-64887221CF02

P478

Q37361889-B69726BC-DA34-4ACA-9D93-9B3AF9E436B8

P50

Q37361889-8370F9BB-3D1D-468C-8C6D-70F5727227DE

Q37361889-B92B6562-883E-4FD1-A353-32BE3A1D8F4F

P577

Q37361889-755F2C68-2B00-4990-AF06-0975BDBFA76C

P5875

Q37361889-71055039-E708-441F-8573-D097984C8222

P698

Q37361889-8CA91DC6-9C16-4C3F-9856-0120F81607AB

P932

Q37361889-6BB19F81-3022-45CA-AD54-C9E227EC2AF4

P356

S12603-013-0430-Z

P1433

The Journal of Nutrition, Health and Aging

P1476

Relationship between use of proton pump inhibitors and IGF system in older subjects

@en

P2093

A Corsonello

http://www.w3.org/2001/XMLSchema#string

A M Abbatecola

http://www.w3.org/2001/XMLSchema#string

C Cattabiani

http://www.w3.org/2001/XMLSchema#string

E Dall'aglio

http://www.w3.org/2001/XMLSchema#string

E Sutti

http://www.w3.org/2001/XMLSchema#string

F De Vita

http://www.w3.org/2001/XMLSchema#string

F Lattanzio

http://www.w3.org/2001/XMLSchema#string

G Bondi

http://www.w3.org/2001/XMLSchema#string

L Ferrucci

http://www.w3.org/2001/XMLSchema#string

M Maggio

http://www.w3.org/2001/XMLSchema#string

P2860

Overutilization of proton-pump inhibitors: what the clinician needs to know

Risk factors for disability in older persons over 3-year follow-up.

Proton pump inhibitors and risk for recurrent Clostridium difficile infection.

Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies.

Effect of proton pump inhibitors on vitamins and iron.

Effects of ACE-inhibition on IGF-1 and IGFBP-3 concentrations in older adults with high cardiovascular risk profile.

Omeprazole stimulates the induction of human insulin-like growth factor binding protein-1 through aryl hydrocarbon receptor activation

Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study).

Insulin-like growth factor-1 bioactivity plays a prosurvival role in older participants.

Adverse effects of proton pump inhibitor drugs: clues and conclusions.

P2888

s12603-013-0430-z

P304

420-423

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12603-013-0430-Z

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Gian Paolo Ceda

Fulvio Lauretani

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261187591

http://www.w3.org/2001/XMLSchema#string

P698

24676324

http://www.w3.org/2001/XMLSchema#string

P932

5077149

http://www.w3.org/2001/XMLSchema#string